Elizabeth Gensterblum-Miller , Apurva Bhangale , Dana Al Majid , Victor Murcia Pienkowski , Malgorzata Rydzanicz , Joanna Janiszewska , Magdalena Kostrzewska-Poczekaj , Clifford Chang , Collin Brummel , Nicole L. Michmerhuizen , Jiayu Wang , Erin Sandford , Muneesh Tewari , Malgorzata Wierzbicka , Andrew C. Birkeland , Jonathan B. McHugh , Matthew E. Spector , Maciej Giefing , Malgorzata Jarmuz-Szymczak , Molly E. Heft Neal , J. Chad Brenner
{"title":"长读测序发现粘液表皮样癌中存在复杂的结构变异和复发性TERT重排。","authors":"Elizabeth Gensterblum-Miller , Apurva Bhangale , Dana Al Majid , Victor Murcia Pienkowski , Malgorzata Rydzanicz , Joanna Janiszewska , Magdalena Kostrzewska-Poczekaj , Clifford Chang , Collin Brummel , Nicole L. Michmerhuizen , Jiayu Wang , Erin Sandford , Muneesh Tewari , Malgorzata Wierzbicka , Andrew C. Birkeland , Jonathan B. McHugh , Matthew E. Spector , Maciej Giefing , Malgorzata Jarmuz-Szymczak , Molly E. Heft Neal , J. Chad Brenner","doi":"10.1016/j.oraloncology.2024.107108","DOIUrl":null,"url":null,"abstract":"<div><div>Mucoepidermoid Carcinoma (MEC) is a common salivary malignant neoplasm. Approximately 60 % of MECs harbor translocations between <em>CRTC1</em> or <em>CRTC3</em> and <em>MAML2</em>, which are thought to drive disease pathogenesis. However, the precise structural mechanism driving this rearrangement remains uncharacterized. Here, we performed multi-omic and long read genomic sequencing, discovering a chain of alterations that created the <em>CRTC1::MAML2</em> fusion, but also an unexpected <em>MAML2</em> to <em>MYBL1</em> rearrangement, suggesting that <em>MYBL1</em> may play a larger role in salivary gland cancers than previously recognized. Furthermore, we discovered and validated recurrent <em>TERT</em> rearrangements and amplifications in MEC models. 5/5 MEC cell lines and 36/39 (92 %) primary MEC tumors harbored a <em>TERT</em> rearrangement or copy number amplification. Custom sequencing of the <em>TERT</em> locus confirmed translocation breakpoints in 13/33 (39 %) MECs, while exome sequencing confirmed frequent <em>TERT</em> amplifications. Critically, <em>TERT</em> knockdown in NCI-H292, a cell line with <em>TERT</em> promoter rearrangement, reduced clonogenic cell survival, supporting a critical role of this gene in MEC tumorigenesis. Overall, our data suggest that complex chromothripsis rearrangement mechanisms drive the formation of structural variation in <em>CRTC1::MAML2</em> fusion positive and negative tumors and reveal highly recurrent structural variation driving <em>TERT</em> rearrangement in MEC.</div></div>","PeriodicalId":19716,"journal":{"name":"Oral oncology","volume":"159 ","pages":"Article 107108"},"PeriodicalIF":4.0000,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Long read sequencing identifies complex structural variant landscape and recurrent TERT rearrangements in mucoepidermoid carcinoma\",\"authors\":\"Elizabeth Gensterblum-Miller , Apurva Bhangale , Dana Al Majid , Victor Murcia Pienkowski , Malgorzata Rydzanicz , Joanna Janiszewska , Magdalena Kostrzewska-Poczekaj , Clifford Chang , Collin Brummel , Nicole L. Michmerhuizen , Jiayu Wang , Erin Sandford , Muneesh Tewari , Malgorzata Wierzbicka , Andrew C. Birkeland , Jonathan B. McHugh , Matthew E. Spector , Maciej Giefing , Malgorzata Jarmuz-Szymczak , Molly E. Heft Neal , J. Chad Brenner\",\"doi\":\"10.1016/j.oraloncology.2024.107108\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Mucoepidermoid Carcinoma (MEC) is a common salivary malignant neoplasm. Approximately 60 % of MECs harbor translocations between <em>CRTC1</em> or <em>CRTC3</em> and <em>MAML2</em>, which are thought to drive disease pathogenesis. However, the precise structural mechanism driving this rearrangement remains uncharacterized. Here, we performed multi-omic and long read genomic sequencing, discovering a chain of alterations that created the <em>CRTC1::MAML2</em> fusion, but also an unexpected <em>MAML2</em> to <em>MYBL1</em> rearrangement, suggesting that <em>MYBL1</em> may play a larger role in salivary gland cancers than previously recognized. Furthermore, we discovered and validated recurrent <em>TERT</em> rearrangements and amplifications in MEC models. 5/5 MEC cell lines and 36/39 (92 %) primary MEC tumors harbored a <em>TERT</em> rearrangement or copy number amplification. Custom sequencing of the <em>TERT</em> locus confirmed translocation breakpoints in 13/33 (39 %) MECs, while exome sequencing confirmed frequent <em>TERT</em> amplifications. Critically, <em>TERT</em> knockdown in NCI-H292, a cell line with <em>TERT</em> promoter rearrangement, reduced clonogenic cell survival, supporting a critical role of this gene in MEC tumorigenesis. Overall, our data suggest that complex chromothripsis rearrangement mechanisms drive the formation of structural variation in <em>CRTC1::MAML2</em> fusion positive and negative tumors and reveal highly recurrent structural variation driving <em>TERT</em> rearrangement in MEC.</div></div>\",\"PeriodicalId\":19716,\"journal\":{\"name\":\"Oral oncology\",\"volume\":\"159 \",\"pages\":\"Article 107108\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2024-11-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oral oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1368837524004263\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"DENTISTRY, ORAL SURGERY & MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1368837524004263","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
Long read sequencing identifies complex structural variant landscape and recurrent TERT rearrangements in mucoepidermoid carcinoma
Mucoepidermoid Carcinoma (MEC) is a common salivary malignant neoplasm. Approximately 60 % of MECs harbor translocations between CRTC1 or CRTC3 and MAML2, which are thought to drive disease pathogenesis. However, the precise structural mechanism driving this rearrangement remains uncharacterized. Here, we performed multi-omic and long read genomic sequencing, discovering a chain of alterations that created the CRTC1::MAML2 fusion, but also an unexpected MAML2 to MYBL1 rearrangement, suggesting that MYBL1 may play a larger role in salivary gland cancers than previously recognized. Furthermore, we discovered and validated recurrent TERT rearrangements and amplifications in MEC models. 5/5 MEC cell lines and 36/39 (92 %) primary MEC tumors harbored a TERT rearrangement or copy number amplification. Custom sequencing of the TERT locus confirmed translocation breakpoints in 13/33 (39 %) MECs, while exome sequencing confirmed frequent TERT amplifications. Critically, TERT knockdown in NCI-H292, a cell line with TERT promoter rearrangement, reduced clonogenic cell survival, supporting a critical role of this gene in MEC tumorigenesis. Overall, our data suggest that complex chromothripsis rearrangement mechanisms drive the formation of structural variation in CRTC1::MAML2 fusion positive and negative tumors and reveal highly recurrent structural variation driving TERT rearrangement in MEC.
期刊介绍:
Oral Oncology is an international interdisciplinary journal which publishes high quality original research, clinical trials and review articles, editorials, and commentaries relating to the etiopathogenesis, epidemiology, prevention, clinical features, diagnosis, treatment and management of patients with neoplasms in the head and neck.
Oral Oncology is of interest to head and neck surgeons, radiation and medical oncologists, maxillo-facial surgeons, oto-rhino-laryngologists, plastic surgeons, pathologists, scientists, oral medical specialists, special care dentists, dental care professionals, general dental practitioners, public health physicians, palliative care physicians, nurses, radiologists, radiographers, dieticians, occupational therapists, speech and language therapists, nutritionists, clinical and health psychologists and counselors, professionals in end of life care, as well as others interested in these fields.